Company Deep Dive

Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.

Request Deep Dive(50 Feathers)

6709.TWO

STRONG SELL

Advagene Biopharma Co., Ltd. · Healthcare · Taiwan · $54M · Avg Vol: $60K/d

13
StockRank
Q
39
V
23
M
33
P/E (TTM)
—
ROE
-36.6%
D/E
0.0x
Dividend %
—
Director Trades · 180d
None in 180d →
Buybacks · 180d
None in 180d →

COMPANY DESCRIPTION

Advagene Biopharma Co., Ltd. is a biotechnology company focused on developing mucosal vaccines and immunotherapies using its proprietary LTh(alpha) adjuvant platform. The company targets infectious diseases and oncology, advancing candidates through clinical trials. Its competitive position is secured by robust global patents covering its adjuvant technology and delivery systems.

Loading...
PRICE (1Y)-0.6%
0.770.800.820.840.86May 14Jun 4Jun 25
SMA 50SMA 200
Close
$0.79
RSI (14)
43.3
52W High
$1.30
From 52W High
0.6%

SCORE BREAKDOWN

Quality
39
ROIC
-44.0%16.4
ROE
-36.6%22.4
GP/Assets
—N/A
Op. Margin
0.0%40.3
FCF/Assets
-25.1%12.4
Piotroski
238.9
Int. Cover
-50.0x6.0
D/E Ratio
0.03x80.5
Current Ratio
13.69x91.5
Value
23
P/E (TTM)
—N/A
EV/EBITDA
-20.9x25.0
P/FCF
—N/A
P/B
10.1x11.5
P/S
—N/A
Div Yield
—N/A
Momentum
33
52W High %
61%45.9
RS 6M
-80%N/A
SMA 50/200
0.88x41.3
EPS Rev 4W
—N/A
EPS Rev 12W
—N/A
EPS Improve
—N/A
Q Growth
—N/A

FUNDAMENTALS

Market Cap
$54M
P/E (Forward)
—
Gross Margin
0.0%

SECTOR PEERS

Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of 6709.TWO are excluded.

TickerCompanyMkt CapStockRankSignal
6709.TWOAdvagene Biopharma Co., Ltd.(you)$54M13STRONG SELL
4168.TWOGlycoNex Incorporation$91M17STRONG SELL
6733.TWOBioGend Therapeutics Co., Ltd.$102M12STRONG SELL
6885.TWBRIM Biotechnology, Inc.$91M9STRONG SELL
6461.TWOIntech Biopharm Corporation$84M6STRONG SELL
6838.TWFormosa Pharmaceuticals, Inc.$116M15STRONG SELL
4178.TWStemCyte International, Ltd.$117M12STRONG SELL
6657.TWEnergenesis Biomedical CO.,LTD.$101M8STRONG SELL
6492.TWOSenhwa Biosciences, Inc.$121M17STRONG SELL
MENSJyong Biotech Ltd.$121M4STRONG SELL

Peer medians: ROE 3.6% · P/E 16.2x · Gross margin 42.1%

Advagene Biopharma Co., Ltd. (6709.TWO) — Stock Score Summary

Advagene Biopharma Co., Ltd. (6709.TWO) has a MoatMap StockRank of 13/100 based on Quality (39/100), Value (23/100), and Momentum (33/100) factor scores. The current signal is STRONG SELL.

Advagene Biopharma Co., Ltd. is a biotechnology company focused on developing mucosal vaccines and immunotherapies using its proprietary LTh(alpha) adjuvant platform. The company targets infectious diseases and oncology, advancing candidates through clinical trials. Its competitive position is secured by robust global patents covering its adjuvant technology and delivery systems.

Key Financial Metrics

Price$0.79
Market Cap$54M
Price/Book10.10
Return on Equity-36.6%
Return on Invested Capital-44.0%
Debt/Equity2.61
Gross Margin0.0%
Operating Margin0.0%
Free Cash Flow$-42K

Advagene Biopharma Co., Ltd. operates in the Biotechnology industry, part of the Healthcare sector (Taiwan).

Frequently Asked Questions

What is Advagene Biopharma Co., Ltd.’s (6709.TWO) StockRank?
MoatMap’s StockRank for Advagene Biopharma Co., Ltd. (6709.TWO) is 13/100, with a Strong Sell signal. It is a composite of Quality (39), Value (23), and Momentum (33) factor ranks across MoatMap’s 20,000+ stock universe.
Does Advagene Biopharma Co., Ltd. have an economic moat?
Advagene Biopharma Co., Ltd. (6709.TWO) has a Quality factor score of 39/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Advagene Biopharma Co., Ltd. a buy, hold, or sell?
MoatMap’s current signal for Advagene Biopharma Co., Ltd. (6709.TWO) is Strong Sell, based on a StockRank of 13/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is Advagene Biopharma Co., Ltd. in?
Advagene Biopharma Co., Ltd. (6709.TWO) operates in the Healthcare sector, specifically the Biotechnology industry (Taiwan).
Browse all ranked stocks6709.TWO deep dive reportAI ChampionsHow we score stocksSense-check another stock